Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Journal of Pharmaceutical and Biomedical Analysis|June 13, 2006
Simple determination of the HIV protease inhibitor atazanavir in human plasma by high-performance liquid chromatography with UV detectionArianna Loregian, Silvana Pagni, Elisa Ballarin, et al.
Molecular Cell|July 21, 2004
The cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped dimerBrent A Appleton, Arianna Loregian, David J Filman, et al.
Scientific Reports|April 18, 2018
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cellsLorenzo Messa, Marta Celegato, Chiara Bertagnin, et al.
Viruses|June 2, 2021
Divide et impera: An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral ReplicationHanieh Ghassabian, Federico Falchi, Martina Timmoneri, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2010
Sulfated derivatives of Escherichia coli K5 capsular polysaccharide are potent inhibitors of human cytomegalovirusBeatrice Mercorelli, Pasqua Oreste, Elisa Sinigalia, et al.
Cell Chemical Biology|February 16, 2016
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus ReplicationBeatrice Mercorelli, Anna Luganini, Giulio Nannetti, et al.
Journal of Virology|August 27, 2010
The carboxy-terminal segment of the human cytomegalovirus DNA polymerase accessory subunit UL44 is crucial for viral replicationLaurie A Silva, Arianna Loregian, Gregory S Pari, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2012
Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B virusesGiulia Muratore, Beatrice Mercorelli, Laura Goracci, et al.
Viruses|September 26, 2013
Regulated transport into the nucleus of herpesviridae DNA replication core proteinsAlvisi Gualtiero, David A Jans, Daria Camozzi, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2020
The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus ReplicationBeatrice Mercorelli, Anna Luganini, Marta Celegato, et al.
Pageof 11